Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Perrone

Showing results (21-30 of 160) with videos related to

Pageof 16
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2019
Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesotheliomaSilvia Brich, Fabio Bozzi, Federica Perrone, et al.
Tumori|July 31, 2014
BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelinesFrancesca Molinari, Stefano Signoroni, Andrea Lampis, et al.
Annals of Surgical Oncology|September 7, 2024
Circulating Tumor DNA in Patients with Desmoid Fibromatosis during Active SurveillanceLaura Bergamaschi, Marta Zorza, Francesca Rini, et al.
Head & Neck|August 15, 2006
Phenotype-genotype correlation: challenge of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinusesMilo Frattini, Federica Perrone, Simona Suardi, et al.
Translational Oncology|May 5, 2009
Polymorphisms of Metabolizing Enzymes and Susceptibility to Ethmoid Intestinal-type Adenocarcinoma in Professionally Exposed PatientsElisa Pastore, Federica Perrone, Marta Orsenigo, et al.
Head & Neck|January 18, 2019
Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neckAurora Mirabile, Rosalba Miceli, Rosa Gioia Calderone, et al.
Molecular Oncology|October 13, 2014
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinomaSabrina Pricl, Barbara Cortelazzi, Valentina Dal Col, et al.
Science Immunology|August 9, 2024
SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlinesIda Paciello, Giuseppe Maccari, Giulio Pierleoni, et al.
Neuro-Oncology|February 28, 2009
PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumorFederica Perrone, Luca Da Riva, Marta Orsenigo, et al.
International Journal of Molecular Sciences|September 28, 2024
Unveiling the Spectrum of Minor Genes in Cardiomyopathies: A Narrative ReviewCaterina Micolonghi, Federica Perrone, Marco Fabiani, et al.
Pageof 16

Showing results (21-30 of 160) with videos related to

Sort By:
Pageof 16
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2019
Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesotheliomaSilvia Brich, Fabio Bozzi, Federica Perrone, et al.
Tumori|July 31, 2014
BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelinesFrancesca Molinari, Stefano Signoroni, Andrea Lampis, et al.
Annals of Surgical Oncology|September 7, 2024
Circulating Tumor DNA in Patients with Desmoid Fibromatosis during Active SurveillanceLaura Bergamaschi, Marta Zorza, Francesca Rini, et al.
Head & Neck|August 15, 2006
Phenotype-genotype correlation: challenge of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinusesMilo Frattini, Federica Perrone, Simona Suardi, et al.
Translational Oncology|May 5, 2009
Polymorphisms of Metabolizing Enzymes and Susceptibility to Ethmoid Intestinal-type Adenocarcinoma in Professionally Exposed PatientsElisa Pastore, Federica Perrone, Marta Orsenigo, et al.
Head & Neck|January 18, 2019
Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neckAurora Mirabile, Rosalba Miceli, Rosa Gioia Calderone, et al.
Molecular Oncology|October 13, 2014
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinomaSabrina Pricl, Barbara Cortelazzi, Valentina Dal Col, et al.
Science Immunology|August 9, 2024
SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlinesIda Paciello, Giuseppe Maccari, Giulio Pierleoni, et al.
Neuro-Oncology|February 28, 2009
PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumorFederica Perrone, Luca Da Riva, Marta Orsenigo, et al.
International Journal of Molecular Sciences|September 28, 2024
Unveiling the Spectrum of Minor Genes in Cardiomyopathies: A Narrative ReviewCaterina Micolonghi, Federica Perrone, Marco Fabiani, et al.
Pageof 16